{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T21:51:24Z","timestamp":1753739484660},"reference-count":63,"publisher":"Elsevier","isbn-type":[{"value":"9780128002124","type":"print"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/b978-0-12-800212-4.00062-5","type":"book-chapter","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T16:16:22Z","timestamp":1459527382000},"page":"672-680","source":"Crossref","is-referenced-by-count":2,"title":["Recreational Use of Ketamine and Its Interaction with NMDA Receptors"],"prefix":"10.1016","author":[{"given":"Lu\u00eds","family":"F\u00e9lix","sequence":"first","affiliation":[]},{"given":"Lu\u00eds","family":"Antunes","sequence":"additional","affiliation":[]},{"given":"S\u00f3nia","family":"Campos","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Ven\u00e2ncio","sequence":"additional","affiliation":[]},{"given":"Ana Maria","family":"Coimbra","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/B978-0-12-800212-4.00062-5_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/0091270009337941","article-title":"Pharmacological aspects and potential new clinical applications of ketamine: reevaluation of an old drug","volume":"49","author":"Aroni","year":"2009","journal-title":"Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1016\/B978-0-12-800212-4.00062-5_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0896-6273(94)90021-3","article-title":"The naming of voltage-gated calcium channels","volume":"13","author":"Birnbaumer","year":"1994","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/B978-0-12-800212-4.00062-5_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/2045125313507739","article-title":"Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy","volume":"4","author":"Caddy","year":"2014","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"10.1016\/B978-0-12-800212-4.00062-5_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fnmol.2013.00014","article-title":"Alcohol and NMDA receptor: current research and future direction","volume":"6","author":"Chandrasekar","year":"2013","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"5087","key":"10.1016\/B978-0-12-800212-4.00062-5_bib5","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1126\/science.1359647","article-title":"The time course of glutamate in the synaptic cleft","volume":"258","author":"Clements","year":"1992","journal-title":"Science"},{"issue":"5","key":"10.1016\/B978-0-12-800212-4.00062-5_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jps.2600710516","article-title":"Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans","volume":"71","author":"Clements","year":"1982","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"3","key":"10.1016\/B978-0-12-800212-4.00062-5_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0959-4388(00)00215-4","article-title":"NMDA receptor subunits: diversity, development and disease","volume":"11","author":"Cull-Candy","year":"2001","journal-title":"Current Opinion in Neurobiology"},{"issue":"4","key":"10.1016\/B978-0-12-800212-4.00062-5_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1360-0443.2000.9545759.x","article-title":"Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later","volume":"95","author":"Curran","year":"2000","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/B978-0-12-800212-4.00062-5_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archgenpsychiatry.2007.37","article-title":"Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study","volume":"65","author":"Deakin","year":"2008","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1016\/B978-0-12-800212-4.00062-5_bib63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0376-8716(02)00243-0","article-title":"Patterns of use and harms associated with non-medical ketamine use","volume":"69","author":"Dillon","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/B978-0-12-800212-4.00062-5_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cpt196563279","article-title":"Pharmacologic effects of Ci-581, a new dissociative anesthetic, in man","volume":"6","author":"Domino","year":"1965","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/B978-0-12-800212-4.00062-5_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.toxlet.2013.03.030","article-title":"Developmental neurotoxicity of ketamine in pediatric clinical use","volume":"220","author":"Dong","year":"2013","journal-title":"Toxicology Letters"},{"key":"10.1016\/B978-0-12-800212-4.00062-5_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ntt.2013.11.005","article-title":"Ketamine NMDA receptor-independent toxicity during zebrafish (Danio rerio) embryonic development","volume":"41","author":"F\u00e9lix","year":"2014","journal-title":"Neurotoxicoly and Teratology"},{"issue":"3","key":"10.1016\/B978-0-12-800212-4.00062-5_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1520\/JFS14742J","article-title":"Ketamine in non-hospital and hospital deaths in New York City","volume":"45","author":"Gill","year":"2000","journal-title":"Journal of Forensic Sciences"},{"issue":"11 Suppl. 8","key":"10.1016\/B978-0-12-800212-4.00062-5_bib14","first-page":"S7","article-title":"Anatomy and physiology of glutamate in the CNS","volume":"44","author":"Greenamyre","year":"1994","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/B978-0-12-800212-4.00062-5_bib15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pneurobio.2005.10.008","article-title":"N-methyl-d-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention?","volume":"77","author":"Haddad","year":"2005","journal-title":"Progress in Neurobiology"},{"issue":"1","key":"10.1016\/B978-0-12-800212-4.00062-5_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1432-1033.2003.03907.x","article-title":"Glutamate signaling in peripheral tissues","volume":"271","author":"Hinoi","year":"2004","journal-title":"European Journal of Biochemistry"},{"issue":"4","key":"10.1016\/B978-0-12-800212-4.00062-5_bib17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/bja\/77.4.441","article-title":"Ketamine: its mechanism(s) of action and unusual clinical uses","volume":"77","author":"Hirota","year":"1996","journal-title":"British Journal of Anaesthesia"},{"issue":"4","key":"10.1016\/B978-0-12-800212-4.00062-5_bib18","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1073\/pnas.85.4.1307","article-title":"Block of N-methyl-d-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels","volume":"85","author":"Huettner","year":"1988","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5398","key":"10.1016\/B978-0-12-800212-4.00062-5_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.283.5398.70","article-title":"Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain","volume":"283","author":"Ikonomidou","year":"1999","journal-title":"Science"},{"issue":"4","key":"10.1016\/B978-0-12-800212-4.00062-5_bib20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/02791072.2000.10400244","article-title":"A review of the nonmedical use of ketamine: use, users and consequences","volume":"32","author":"Jansen","year":"2000","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/B978-0-12-800212-4.00062-5_bib21","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.3402\/ehtj.v4i0.7107","article-title":"The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use","volume":"4","author":"Kalsi","year":"2011","journal-title":"Emerging Health Threats Journal"},{"issue":"4","key":"10.1016\/B978-0-12-800212-4.00062-5_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0740-5472(02)00275-1","article-title":"Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up","volume":"23","author":"Krupitsky","year":"2002","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/B978-0-12-800212-4.00062-5_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/02791072.1997.10400185","article-title":"Ketamine psychedelic therapy (KPT): a review of the results of ten years of research","volume":"29","author":"Krupitsky","year":"1997","journal-title":"Journal of Psychoactive Drugs"},{"issue":"3","key":"10.1016\/B978-0-12-800212-4.00062-5_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Archives of General Psychiatry"},{"issue":"29","key":"10.1016\/B978-0-12-800212-4.00062-5_bib25","doi-asserted-by":"crossref","first-page":"21913","DOI":"10.1074\/jbc.M109.087338","article-title":"Activation of N-methyl-d-aspartate (NMDA) receptors in the dorsal vagal complex lowers glucose production","volume":"285","author":"Lam","year":"2010","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/B978-0-12-800212-4.00062-5_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/102490791101800404","article-title":"A retrospective survey on the clinical presentation of ketamine abusers in a Hong Kong emergency department","volume":"18","author":"Lee","year":"2011","journal-title":"Hong Kong Journal of Emergency Medicine"},{"issue":"Pt 7","key":"10.1016\/B978-0-12-800212-4.00062-5_bib27","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/brain\/awq131","article-title":"Frontal white matter abnormalities following chronic ketamine use: a diffusion tensor imaging study","volume":"133","author":"Liao","year":"2010","journal-title":"Brain"},{"issue":"2","key":"10.1016\/B978-0-12-800212-4.00062-5_bib28","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/toxsci\/kfs296","article-title":"Ketamine-induced neuronal damage and altered N-methyl-d-aspartate receptor function in rat primary forebrain culture","volume":"131","author":"Liu","year":"2013","journal-title":"Toxicological Sciences"},{"key":"10.1016\/B978-0-12-800212-4.00062-5_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/SAR.S15458","article-title":"To use or not to use: an update on licit and illicit ketamine use","volume":"2","author":"Li","year":"2011","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"6","key":"10.1016\/B978-0-12-800212-4.00062-5_bib30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cns.12099","article-title":"Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings)","volume":"19","author":"Mion","year":"2013","journal-title":"CNS Neuroscience and Therapeutics"},{"issue":"8","key":"10.1016\/B978-0-12-800212-4.00062-5_bib31","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"The Journal of Neuroscience"},{"issue":"7","key":"10.1016\/B978-0-12-800212-4.00062-5_bib32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jat\/25.7.583","article-title":"Urine concentrations of ketamine and norketamine following illegal consumption","volume":"25","author":"Moore","year":"2001","journal-title":"Journal of Analytical Toxicology"},{"issue":"4","key":"10.1016\/B978-0-12-800212-4.00062-5_bib33","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00213-006-0572-3","article-title":"Acute and chronic effects of ketamine upon human memory: a review","volume":"188","author":"Morgan","year":"2006","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/B978-0-12-800212-4.00062-5_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1360-0443.2011.03576.x","article-title":"Ketamine use: a review","volume":"107","author":"Morgan","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/B978-0-12-800212-4.00062-5_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2014.00149","article-title":"Long-term heavy ketamine use is associated with spatial memory impairment and altered hippocampal activation","volume":"5","author":"Morgan","year":"2014","journal-title":"Frontiers in Psychiatry"},{"issue":"3","key":"10.1016\/B978-0-12-800212-4.00062-5_bib36","first-page":"565","article-title":"NMDA receptor antagonists and pain: ketamine","volume":"26","author":"Muir","year":"2010","journal-title":"Veterinary Clinics of North America: Equine Practice"},{"issue":"12","key":"10.1016\/B978-0-12-800212-4.00062-5_bib37","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1176\/appi.ajp.162.12.2352","article-title":"Altered prefrontal dopaminergic function in chronic recreational ketamine users","volume":"162","author":"Narendran","year":"2005","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/B978-0-12-800212-4.00062-5_bib38","first-page":"6","article-title":"Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases","volume":"16","author":"Ng","year":"2010","journal-title":"Hong Kong Medical Journal"},{"issue":"1\u20132","key":"10.1016\/B978-0-12-800212-4.00062-5_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(88)90765-2","article-title":"Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced","volume":"451","author":"Novelli","year":"1988","journal-title":"Brain Research"},{"issue":"4","key":"10.1016\/B978-0-12-800212-4.00062-5_bib40","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00000542-199704000-00021","article-title":"Multiple mechanisms of ketamine blockade of N-methyl-d-aspartate receptors","volume":"86","author":"Orser","year":"1997","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/B978-0-12-800212-4.00062-5_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/bjaceaccp\/mkm008","article-title":"Ketamine","volume":"7","author":"Pai","year":"2007","journal-title":"Continuing Education in Anaesthesia, Critical Care and Pain"},{"issue":"6","key":"10.1016\/B978-0-12-800212-4.00062-5_bib42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nature Reviews Neuroscience"},{"issue":"3","key":"10.1016\/B978-0-12-800212-4.00062-5_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/08998280.2014.11929117","article-title":"Multiorgan dysfunction related to chronic ketamine abuse","volume":"27","author":"Pappachan","year":"2014","journal-title":"Proceedings (Baylor University. Medical Center)"},{"issue":"51","key":"10.1016\/B978-0-12-800212-4.00062-5_bib44","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1016\/j.chroma.2010.06.028","article-title":"Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in\u00a0vitro","volume":"1217","author":"Portmann","year":"2010","journal-title":"Journal of Chromatography A"},{"issue":"3","key":"10.1016\/B978-0-12-800212-4.00062-5_bib45","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jpainsymman.2011.01.001","article-title":"Ketamine\u2217","volume":"41","author":"Quibell","year":"2011","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1016\/B978-0-12-800212-4.00062-5_bib46","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF03011442","article-title":"Ketamine: an update on the first twenty-five years of clinical experience","volume":"36","author":"Reich","year":"1989","journal-title":"Canadian Journal of Anesthesia"},{"issue":"2","key":"10.1016\/B978-0-12-800212-4.00062-5_bib47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/npp.2013.195","article-title":"Abnormalities in white matter microstructure associated with chronic ketamine use","volume":"39","author":"Roberts","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"10.1016\/B978-0-12-800212-4.00062-5_bib48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-4274(02)00008-5","article-title":"The role of ketamine on plasma cocaine pharmacokinetics in rat","volume":"129","author":"Rofael","year":"2002","journal-title":"Toxicology Letters"},{"issue":"9","key":"10.1016\/B978-0-12-800212-4.00062-5_bib49","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.pain.2011.04.031","article-title":"Ketamine hepato-toxicity in chronic pain management: another example of unexpected toxicity or a predicted result from previous clinical and pre-clinical data?","volume":"152","author":"Sear","year":"2011","journal-title":"Pain"},{"issue":"48","key":"10.1016\/B978-0-12-800212-4.00062-5_bib50","doi-asserted-by":"crossref","first-page":"19407","DOI":"10.1073\/pnas.1112052108","article-title":"Heroin relapse requires long-term potentiation-like plasticity mediated by NMDA2b-containing receptors","volume":"108","author":"Shen","year":"2011","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/B978-0-12-800212-4.00062-5_bib51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-3-540-74806-9_15","article-title":"Ketamine","volume":"182","author":"Sinner","year":"2008","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"11","key":"10.1016\/B978-0-12-800212-4.00062-5_bib52","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/ajhp\/59.11.1067","article-title":"Club drugs: methylenedioxy-methamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate","volume":"59","author":"Smith","year":"2002","journal-title":"American Journal of Health System Pharmacy"},{"issue":"1","key":"10.1016\/B978-0-12-800212-4.00062-5_bib53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/13543784.2012.638916","article-title":"Investigational NMDA receptor modulators for depression","volume":"21","author":"Szewczyk","year":"2012","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"3","key":"10.1016\/B978-0-12-800212-4.00062-5_bib54","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacological Reviews"},{"issue":"12\u201314","key":"10.1016\/B978-0-12-800212-4.00062-5_bib55","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.lfs.2013.08.001","article-title":"Chronic ketamine administration impairs mitochondrial complex I in the rat liver","volume":"93","author":"Ven\u00e2ncio","year":"2013","journal-title":"Life Sciences"},{"issue":"4","key":"10.1016\/B978-0-12-800212-4.00062-5_bib56","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuroscience.2005.01.053","article-title":"The role of the N-methyl-d-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture","volume":"132","author":"Wang","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/B978-0-12-800212-4.00062-5_bib57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fnana.2013.00023","article-title":"Brain damages in ketamine addicts as revealed by magnetic resonance imaging","volume":"7","author":"Wang","year":"2013","journal-title":"Frontiers in Neuroanatomy"},{"issue":"4","key":"10.1016\/B978-0-12-800212-4.00062-5_bib58","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0736-4679(00)00162-1","article-title":"Ketamine abusers presenting to the emergency department: a case series","volume":"18","author":"Weiner","year":"2000","journal-title":"Journal of Emergency Medicine"},{"issue":"2","key":"10.1016\/B978-0-12-800212-4.00062-5_bib59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00000542-198202000-00007","article-title":"Ketamine\u2013its pharmacology and therapeutic uses","volume":"56","author":"White","year":"1982","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/B978-0-12-800212-4.00062-5_bib60","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00023210-200620030-00003","article-title":"Ketamine: from medicine to misuse","volume":"20","author":"Wolff","year":"2006","journal-title":"CNS Drugs"},{"issue":"7","key":"10.1016\/B978-0-12-800212-4.00062-5_bib61","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3109\/00498258709043993","article-title":"Biotransformation of ketamine, (Z)-6-hydroxyketamine, and (E)-6-hydroxyketamine by rat, rabbit, and human liver microsomal preparations","volume":"17","author":"Woolf","year":"1987","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/B978-0-12-800212-4.00062-5_bib62","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2125.2012.04198.x","article-title":"Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression","volume":"74","author":"Zhao","year":"2012","journal-title":"British Journal of Clinical Pharmacology"}],"container-title":["Neuropathology of Drug Addictions and Substance Misuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128002124000625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128002124000625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T01:43:24Z","timestamp":1567734204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128002124000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9780128002124"],"references-count":63,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-800212-4.00062-5","relation":{},"subject":[],"published":{"date-parts":[[2016]]}}}